$KEY

Goldman Sachs Adjusts Price Target on KeyCorp to $26 From $27, Maintains Buy Rating

Goldman Sachs reduced its price target for KeyCorp from $27 to $26 but maintained a buy rating. KeyCorp's stock is currently at $20.16, up 0.37% on the day but down 1.57% over the week. JPMorgan also recently adjusted its target to $23, keeping a neutral rating.

Original reporting
Published Oct 5, 2026, 1:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 2:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$KEY
Bearish
high confidence
Mentioned
$KEY
Relevance
6/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$KEYBearishMed
01

Why it matters

The target reduction may trigger short‑term sell pressure, but the Buy rating still supports a neutral stance.

02

Market read

Analyst target cuts are a common catalyst for short‑term price moves in bank stocks.

03

What to watch

Potential upside from upcoming loan portfolio growth not reflected in the target.

Relevance 6/10Novelty 5/10Timing: today

Background

Goldman Sachs regularly updates price targets for covered banks; this is the latest adjustment for KeyCorp.

Company-level read

Ticker impact

$KEYBearishHigh confidence
Context

Goldman Sachs lowered its price target for KeyCorp to $26 from $27 and kept a Buy rating.

Expected impact

likely downward pressure as investors price in the lower target

Evidence & confidence

Analyst target cuts are a direct catalyst that often lead to short-term price declines.

Market effects

Minor impact on regional banking sector as analysts reassess valuation multiples.

Limited to U.S. financial markets; no broader macro effect.

Low; the news is company‑specific.

Counterpoint

Some investors may view the target cut as an overreaction and see buying opportunity.

Key entities

  • KeyCorp

    U.S. regional bank (ticker KEY) subject of the analyst target change.

  • Goldman Sachs

    Provider of the price target adjustment.

Related articles

$KEYMed

KeyCorp Reaffirms 2026 Outlook as Loan Growth, Margins and Fees Gain Momentum

KeyCorp (NYSE: KEY) expects average client deposits to rise over 2% in the second half of 2024, with deposit costs increasing only slightly. The company reported a 2.89% net interest margin in Q2 and targets 3% to 3.05% in the near term, aiming for 3.25% or more in 2025. KeyCorp updated its fee-income growth outlook to 4% to 5% and increased its expense outlook to about 4% following the Clearwater acquisition. The bank sees growth in payments and wealth management, with payments platforms showin

$JPMMed

Major U.S. banks raise prime rate after Fed rate hike

Major U.S. banks, including JPMorgan, Bank of America, and others, raised their prime lending rate to 7% after the Federal Reserve's quarter-point rate hike. The move increases borrowing costs for consumers and businesses. Bank stocks fell, with BofA down 2.7%, Citi 2.4%, and JPMorgan 1%. Rate hikes may boost bank earnings but could also slow economic activity and impact credit quality.

$JPMMed

Major US banks raise prime rate after first Fed rate hike since 2023

Top U.S. banks, including JPMorgan and Bank of America, raised their prime lending rate to 7% after the Federal Reserve's first rate hike since 2023. The Fed increased rates by 0.25% and signaled further hikes, aiming to combat inflation. Bank shares fell, with JPMorgan down 1% and Goldman Sachs down 4%. Higher rates boost bank earnings but may slow economic activity and reduce loan demand.

$KEYMed

KeyCorp Raises 2026 Revenue Outlook: What's Driving It?

KeyCorp (KEY) raised its 2026 revenue outlook to 8% growth, up from 7-8%, citing strong loan growth, fee-based business momentum, and the Clearwater acquisition. Non-interest income is now expected to grow 4-5%, with adjusted non-interest income projected to increase 6-7%. The company also affirmed a 20%+ sequential rise in third-quarter investment-banking fees. KeyCorp anticipates 4-5% average loan growth and 9-11% net interest income growth for 2026, supported by solid loan demand and deposit

$KEYMed

KeyCorp Barclays Global Financial Services Conference September 14, 2026 Clark Khayat Chief Financial Officer

KEYCORP /NEW/ (KEY) filed an SEC Form 8-K — Regulation FD Disclosure. KeyCorp Barclays Global Financial Services Conference September 14, 2026 Clark Khayat Chief Financial Officer $ in millions, unless otherwise stated FY2026 (vs. FY2025) On an operating basis Revenue(1),(2) (FY25 baseline: $7,513) up ~8% (previously up 7 – 8%) Net interest income(